CARREFOUR BR (CRFB3) Main Indicators
Basic Data - CRFB3
| Company | CARREFOUR BR |
| Corporate Name | ATACADÃO S.A. |
| Registration Status | ATIVO |
| Issuer Status | FASE OPERACIONAL |
| Listing Segment | Novo Mercado |
| Activity | Comércio varejista e atacadista de mercadorias em geral; Carga e descarga; Correspondentes de instituições financeiras; Atividades de teleatendimento; Serviços de Alimentação entre outros |
| Share | CRFB3 |
| Quote Date | 04/01/2025 |
| Share Type | ON |
| Last Closing | R$ 7.35 |
| Quotation Factor | 1 Share |
| Financial Volume | R$ 350.20 M |
| Last Statement | DFP - 12/31/2024 |
| Sector | Consumo não Cíclico |
| Subsector | Comércio e Distribuição |
| Segment | Alimentos |
| Participation Indexes | AGFS, IBOVESPA, IBRA, IBRX, ICO2, ICON, IGC, IGCT, IGNM, ISE, ITAG, IVBX, SMLL |
| Updated 04/02/2025 | |
Relative Prices - CRFB3
| Price/Earnings | 8.84 |
| Price/SBV | 0.74 |
| Price/Net Sales | 0.13 |
| Price/CFO | 3.29 |
| Price/FCF | 4.00 |
| Price/Total Assets | 0.15 |
| Price/EBIT | 3.63 |
| Price/Working Capital | -254.12 |
| Price/NCAV | -0.20 |
| EV/EBIT | 5.91 |
| EV/EBITDA | 4.14 |
| EV/Net Sales | 0.22 |
| EV/CFO | 5.37 |
| EV/FCF | 6.52 |
| EV/Total Assets | 0.25 |
| Company Market Cap | R$ 15.50 B |
| Enterprise Value | R$ 25.26 B |
| Current Financial Statement Date | 12/31/2024 |
| Current Share Price | R$ 7.35 |
| Share Price Date | 04/01/2025 |
| Dividend Yield | 1.29% |
| Updated 04/02/2025 | |
Income Statement - CRFB3
| Net Revenue | R$ 115.64 B |
| Gross Result | R$ 21.18 B |
| EBIT | R$ 4.27 B |
| Depreciation and Amortization | - R$ 1.83 B |
| EBITDA | R$ 6.11 B |
| Net Profit | R$ 1.75 B |
| Net Profit/Share | R$ 0.83 |
| Updated 02/18/2025 | |
| Net Revenue | R$ 31.30 B |
| Gross Result | R$ 5.74 B |
| EBIT | R$ 1.03 B |
| Depreciation and Amortization | - R$ 453.00 M |
| EBITDA | R$ 1.48 B |
| Net Profit | R$ 1.16 B |
| Profit/Share | R$ 0.55 |
| Updated 02/18/2025 | |
Price and Volume Behavior - CRFB3
| Lowest Price 52 weeks | R$ 5.25 |
| Highest Price 52 weeks | R$ 13.44 |
| Variation 2025 | 33.15% |
| Variation 1 year | -44.34% |
| Variation 2 years(total) | -38.89% |
| Variation 2 years(yearly) | -21.78% |
| Variation 3 years(total) | -65.73% |
| Variation 3 years(yearly) | -30.00% |
| Variation 4 years(total) | -64.56% |
| Variation 4 years(yearly) | -22.83% |
| Variation 5 years(total) | -58.47% |
| Variation 5 years(yearly) | -16.11% |
| Average Daily Volume (3 months) | R$ 114.03 M |
| Updated 04/02/2025 | |
Returns and Margins - CRFB3
| Return on Initial Tangible Capital | 7.40% |
| Return on Initial Invested Capital | 9.95% |
| Pre-Tax Return on Initial Tangible Capital | 11.22% |
| Pre-Tax Return on Initial Invested Capital | 15.08% |
| Return on Initial Shareholder´s Equity | 9.12% |
| Return on Initial Asset | 1.89% |
| Gross Margin | 18.31% |
| Net Margin | 1.52% |
| EBIT Margin | 3.69% |
| EBITDA Margin | 5.28% |
| Initial Asset Turnover | 1.25 |
| Financial Leverage | 4.81 |
| Liabilities/Net Worth | 3.81 |
| Net Debt/EBITDA | 1.60 |
| Updated 02/18/2025 | |
Balance Sheet - CRFB3
| Cash and Cash Equivalents | R$ 15.21 B |
| Total Assets | R$ 100.19 B |
| Short-Term Debt | R$ 12.22 B |
| Long-Term Debt | R$ 12.74 B |
| Gross Debt | R$ 24.97 B |
| Net Debt | R$ 9.76 B |
| Shareholder´s Equity | R$ 20.81 B |
| Share Book Value | R$ 9.87 |
| Common Shares | 2,109,056,711 |
| Preferred Shares | 0 |
| Total | 2,109,056,711 |
| Common Shares in Treasury | 0 |
| Preferred Shares in Treasury | 0 |
| Total in Treasury | 0 |
| Common Shares (Except Treasury) | 2,109,056,711 |
| Preferred Shares (Except Treasury) | 0 |
| Total (Except Treasury) | 2,109,056,711 |
| Updated 02/18/2025 | |
Cash Flow - CRFB3
| Operating Cash Flow | R$ 4.71 B |
| Cash Flow from Investments | - R$ 1.03 B |
| Financing Cash Flow | - R$ 502.00 M |
| Increase (Reduction) in Cash and Equivalents | R$ 3.18 B |
| Updated 02/18/2025 | |
| Operating Cash Flow | R$ 9.65 B |
| Cash Flow from Investments | R$ 383.00 M |
| Financing Cash Flow | R$ 1.22 B |
| Increase (Reduction) in Cash and Equivalents | R$ 11.25 B |
| Updated 02/18/2025 | |
Experimental - CRFB3
| CAPEX 3 months | R$ 435.00 M |
| Free Cash Flow 3 months | R$ 10.08 B |
| CAPEX 12 months | - R$ 830.00 M |
| Free Cash Flow 12 months | R$ 3.88 B |
| Updated 02/18/2025 | |